Page 4 - Beyondspring Inc News Today

Each month, Outsourced Pharma works in conjunction with PharmSource, part of GlobalData, to present its “Contract Manufacturing: Opportunities...

18.04.2023 - - SEED Therapeutics, a BeyondSpring Subsidiary, Achieved Milestones on the Eli Lilly Collaboration - BeyondSpring Completed Enrollment of Three Investigator-Initiated Trials (IIT) with Plinabulin in the U.S. for Multiple Cancer Indications NEW ...

/PRNewswire/ -- The marine pharmaceuticals market size is estimated to increase by USD 1.56 billion from 2021 to 2026, with a CAGR of 7.73%, according to a...

But amid this very poor market, I've found one technical buy that's performing well....BYSI

Gainers Allarity Therapeutics, Inc. (NASDAQ:ALLR) gained 240% to $0.90. Allarity Therapeutics, last month, posted a Q3 loss of $0.68 per share. ...

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining 100 points on Tuesday The Dow traded up 0.15% to 34,055.32...

U.S. stocks pared gains midway through trading, with the Dow Jones turning lower on Tuesday The Dow traded down 0.14% to 33,957.30 while the NASD...

BeyondSpring Receives Nasdaq Notice Regarding Minimum Bid Price Requirements - November 23, 2022 - read this article along with other careers information, tips and advice on BioSpace

/PRNewswire/ -- The "Marine Pharmaceuticals Market by Product and Geography - Forecast and Analysis 2022-2026" report has been added to Technavios offering....

Shares of BeyondSpring Inc. (NASDAQ:BYSI – Get Rating) have received a consensus recommendation of “Hold” from the six research firms that are currently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, three have given a hold rating and two have issued a buy rating on the company. […]